From January 1, 2023 to February 2, 2023, the company has repurchased 22,972 shares, representing 0.007245% for CNY 1.67 million. With this, the company has completed the repurchase of 1,459,586 shares, representing 0.46% for CNY 99.69 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.26 CNY | +0.84% | +8.13% | -8.05% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.05% | 1.62B | |
+8.21% | 218B | |
+7.36% | 183B | |
+13.08% | 134B | |
+25.43% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
-0.14% | 40.3B | |
+2.88% | 35.53B | |
+26.53% | 32.05B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.